Iradimed (IRMD) Earnings Date, Estimates & Call Transcripts

$47.51

+0.26 (+0.55%)

(As of 07/26/2024 ET)

Upcoming Earnings Date: Aug. 1
Before Market Opens
Confirmed
Actual EPS (May. 2): $0.32 Beat By $0.01
Consensus EPS (May. 2): $0.31

IRMD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IRMD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Porter & Company

Nvidia insiders dumping shares

All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.

To see Porter Stansberry's new AI prediction go here now.

Iradimed Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2024	1	$0.31	$0.31	$0.31	0.330 - 0.350
Q2 2024	1	$0.35	$0.35	$0.35	0.360 - 0.390
Q3 2024	1	$0.34	$0.34	$0.34
Q4 2024	1	$0.39	$0.39	$0.39
FY 2024	4	$1.39	$1.39		$1.39

IRMD Earnings Date and Information

Iradimed last released its earnings data on May 2nd, 2024. The medical equipment provider reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.01. The business had revenue of $17.60 million for the quarter, compared to the consensus estimate of $17.26 million. Iradimed has generated $1.41 earnings per share over the last year ($1.41 diluted earnings per share) and currently has a price-to-earnings ratio of 33.7. Earnings for Iradimed are expected to grow by 21.28% in the coming year, from $1.41 to $1.71 per share. Iradimed has confirmed that its next quarterly earnings report will be published on Thursday, August 1st, 2024. Iradimed will be holding an earnings conference call on Thursday, August 1st at 12:00 PM Eastern. Interested parties can register for or listen to the call..

Iradimed Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/1/2024 (Confirmed)	-	-	-	-	-	-	-
5/2/2024	Q1 2024	$0.31	$0.32	+$0.01	$0.32	$17.26 million	$17.60 million
2/8/2024	Q4 2023	$0.37	$0.36	($0.01)	$0.36	-	$17.45 million
11/3/2023	Q3 2023	$0.34	$0.40	+$0.06	$0.40	$16.21 million	$16.51 million
8/3/2023	Q2 2023	$0.28	$0.33	+$0.05	$0.33	$15.70 million	$16.13 million
5/4/2023	Q1 2023	$0.25	$0.27	+$0.02	$0.27	$14.76 million	$15.48 million
2/2/2023	Q4 2022	$0.29	$0.29	-	$0.29	$14.93 million	$14.86 million
Get the Latest News and Ratings for IRMD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Iradimed and its competitors with MarketBeat's FREE daily newsletter.
11/3/2022	Q3 2022	$0.23	$0.27	+$0.04	$0.27	$13.17 million	$13.41 million
7/29/2022	Q2 2022	$0.20	$0.26	+$0.06	$0.26	$12.64 million	$12.72 million
4/29/2022	Q1 2022	$0.18	$0.20	+$0.02	$0.20	$12.21 million	$12.31 million
2/3/2022	Q4 2021	$0.21	$0.33	+$0.12	$0.31	$11.66 million	$11.87 million
10/28/2021	Q3 2021	$0.17	$0.23	+$0.06	$0.20	$10.39 million	$10.91 million
7/29/2021	Q2 2021	$0.10	$0.14	+$0.04	$0.12	$9.58 million	$9.81 million
4/29/2021	Q1 2021	$0.10	$0.13	+$0.03	$0.11	$8.36 million	$9.22 million
2/3/2021	Q4 2020	$0.11	$0.07	($0.04)	$0.05	$8.02 million	$8.55 million
11/4/2020	Q3 2020	$0.10	$0.11	+$0.01	$0.09	$7.46 million	$7.70 million
7/30/2020	Q2 2020	($0.07)	$0.05	+$0.12	($0.17)	$5.53 million	$6.80 million
4/30/2020	Q1 2020	$0.15	$0.18	+$0.03	$0.14	$8.72 million	$8.68 million
2/6/2020	Q4 2019	$0.20	$0.30	+$0.10	$0.26	$10.96 million	$10.89 million
10/30/2019	Q3 2019	$0.13	$0.20	+$0.07	$0.20	$9.85 million	$9.96 million
7/30/2019	Q2 2019	$0.12	$0.17	+$0.05	$0.17	$8.91 million	$9.23 million

Iradimed Earnings - Frequently Asked Questions

When is Iradimed's earnings date?: Iradimed has confirmed that its next quarterly earnings data will be published on Thursday, August 1st, 2024. Learn more on IRMD's earnings history.
What guidance has Iradimed issued on next quarter's earnings?: Iradimed issued an update on its second quarter 2024 earnings guidance on Friday, May, 3rd. The company provided EPS guidance of 0.360-0.390 for the period, compared to the consensus earnings per share estimate of 0.370. The company issued revenue guidance of $17.6 million-$17.8 million, compared to the consensus revenue estimate of $17.9 million.
Did Iradimed beat their earnings estimates last quarter?: In the previous quarter, Iradimed (NASDAQ:IRMD) reported $0.32 earnings per share (EPS) to beat the analysts' consensus estimate of $0.31 by $0.01. Learn more on analysts' earnings estimate vs. IRMD's actual earnings.
How much revenue does Iradimed generate each year?: Iradimed (NASDAQ:IRMD) has a recorded annual revenue of $65.56 million.
How much profit does Iradimed generate each year?: Iradimed (NASDAQ:IRMD) has a recorded net income of $17.19 million. IRMD has generated $1.41 earnings per share over the last four quarters.
What is Iradimed's price-to-earnings ratio?: Iradimed (NASDAQ:IRMD) has a trailing price-to-earnings ratio of 33.70 and a forward price-to-earnings ratio of 33.70.
What is Iradimed's EPS forecast for next year?: Iradimed's earnings are expected to grow from $1.41 per share to $1.71 per share in the next year, which is a 21.28% increase.